ABBVIE INC. (ABBV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of ABBVIE INC. (ABBV)
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Key Insights
Critical company metrics and information
Share Price
$176.19Market Cap
$311.35 BillionTotal Outstanding Shares
1.77 Billion SharesTotal Employees
50,000Dividend
$1.64 Per Share QuarterlyIPO Date
December 10, 2012SIC Description
Pharmaceutical PreparationsHomepage
http://www.abbvieinvestor.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities, Continuing | $-19.75 Billion |
Net Cash Flow From Investing Activities | $-19.75 Billion |
Net Cash Flow From Operating Activities, Continuing | $16.51 Billion |
Net Cash Flow From Financing Activities, Continuing | $-2.80 Billion |
Net Cash Flow | $-6.03 Billion |
Exchange Gains/Losses | $4.00 Million |
Net Cash Flow, Continuing | $-6.03 Billion |
Net Cash Flow From Financing Activities | $-2.80 Billion |
Net Cash Flow From Operating Activities | $16.51 Billion |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Diluted Average Shares | $3.54 Billion |
Interest Expense, Operating | $2.67 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.00 Million |
Income Tax Expense/Benefit | $2.06 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $9.00 Million |
Net Income/Loss | $5.13 Billion |
Income/Loss From Continuing Operations Before Tax | $20.29 Billion |
Diluted Earnings Per Share | $2.87 |
Other Operating Expenses | $9.41 Billion |
Revenues | $55.53 Billion |
Income/Loss From Continuing Operations After Tax | $5.13 Billion |
Basic Earnings Per Share | $2.87 |
Operating Income/Loss | $13.82 Billion |
Costs And Expenses | $30.61 Billion |
Selling, General, and Administrative Expenses | $14.09 Billion |
Income Tax Expense/Benefit, Deferred | $-2.07 Billion |
Gross Profit | $37.32 Billion |
Net Income/Loss Attributable To Parent | $5.12 Billion |
Preferred Stock Dividends And Other Adjustments | $30.00 Million |
Basic Average Shares | $3.54 Billion |
Benefits Costs and Expenses | $35.25 Billion |
Cost Of Revenue | $18.21 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $5.09 Billion |
Operating Expenses | $23.50 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Fixed Assets | $5.14 Billion |
Liabilities | $137.35 Billion |
Current Assets | $27.79 Billion |
Noncurrent Liabilities | $94.29 Billion |
Equity Attributable To Noncontrolling Interest | $39.00 Million |
Assets | $143.42 Billion |
Liabilities And Equity | $143.42 Billion |
Current Liabilities | $43.06 Billion |
Noncurrent Assets | $115.64 Billion |
Inventory | $4.45 Billion |
Equity Attributable To Parent | $6.03 Billion |
Equity | $6.07 Billion |
Other Current Assets | $23.34 Billion |
Other Non-current Assets | $43.85 Billion |
Intangible Assets | $66.65 Billion |
Historical Dividends
Current dividend: $1.64 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Oct 30, 2024 | Feb 14, 2025 | Jan 15, 2025 | $1.64 | Quarterly |
Sep 6, 2024 | Nov 15, 2024 | Oct 15, 2024 | $1.55 | Quarterly |
Jun 20, 2024 | Aug 15, 2024 | Jul 15, 2024 | $1.55 | Quarterly |
Feb 15, 2024 | May 15, 2024 | Apr 15, 2024 | $1.55 | Quarterly |
Oct 27, 2023 | Feb 15, 2024 | Jan 16, 2024 | $1.55 | Quarterly |
Sep 8, 2023 | Nov 15, 2023 | Oct 13, 2023 | $1.48 | Quarterly |
Jun 22, 2023 | Aug 15, 2023 | Jul 14, 2023 | $1.48 | Quarterly |
Feb 16, 2023 | May 15, 2023 | Apr 14, 2023 | $1.48 | Quarterly |
Oct 28, 2022 | Feb 15, 2023 | Jan 13, 2023 | $1.48 | Quarterly |
Sep 9, 2022 | Nov 15, 2022 | Oct 14, 2022 | $1.41 | Quarterly |
Jun 23, 2022 | Aug 15, 2022 | Jul 15, 2022 | $1.41 | Quarterly |
Feb 17, 2022 | May 16, 2022 | Apr 15, 2022 | $1.41 | Quarterly |
Oct 29, 2021 | Feb 15, 2022 | Jan 14, 2022 | $1.41 | Quarterly |
Sep 10, 2021 | Nov 15, 2021 | Oct 15, 2021 | $1.3 | Quarterly |
Jun 17, 2021 | Aug 16, 2021 | Jul 15, 2021 | $1.3 | Quarterly |
Feb 18, 2021 | May 14, 2021 | Apr 15, 2021 | $1.3 | Quarterly |
Oct 30, 2020 | Feb 16, 2021 | Jan 15, 2021 | $1.3 | Quarterly |
Sep 11, 2020 | Nov 16, 2020 | Oct 15, 2020 | $1.18 | Quarterly |
Jun 17, 2020 | Aug 14, 2020 | Jul 15, 2020 | $1.18 | Quarterly |
Feb 20, 2020 | May 15, 2020 | Apr 15, 2020 | $1.18 | Quarterly |
Nov 1, 2019 | Feb 14, 2020 | Jan 15, 2020 | $1.18 | Quarterly |
Sep 6, 2019 | Nov 15, 2019 | Oct 15, 2019 | $1.07 | Quarterly |
Jun 20, 2019 | Aug 15, 2019 | Jul 15, 2019 | $1.07 | Quarterly |
Feb 21, 2019 | May 15, 2019 | Apr 15, 2019 | $1.07 | Quarterly |
Nov 2, 2018 | Feb 15, 2019 | Jan 15, 2019 | $1.07 | Quarterly |
Sep 7, 2018 | Nov 15, 2018 | Oct 15, 2018 | $0.96 | Quarterly |
Jun 14, 2018 | Aug 15, 2018 | Jul 13, 2018 | $0.96 | Quarterly |
Feb 15, 2018 | May 15, 2018 | Apr 13, 2018 | $0.96 | Quarterly |
Oct 27, 2017 | Feb 15, 2018 | Jan 12, 2018 | $0.71 | Quarterly |
Sep 8, 2017 | Nov 15, 2017 | Oct 13, 2017 | $0.64 | Quarterly |
Jun 22, 2017 | Aug 15, 2017 | Jul 14, 2017 | $0.64 | Quarterly |
Feb 16, 2017 | May 15, 2017 | Apr 13, 2017 | $0.64 | Quarterly |
Oct 28, 2016 | Feb 15, 2017 | Jan 13, 2017 | $0.64 | Quarterly |
Sep 9, 2016 | Nov 15, 2016 | Oct 14, 2016 | $0.57 | Quarterly |
Jun 16, 2016 | Aug 15, 2016 | Jul 15, 2016 | $0.57 | Quarterly |
Feb 18, 2016 | May 16, 2016 | Apr 15, 2016 | $0.57 | Quarterly |
Oct 30, 2015 | Feb 16, 2016 | Jan 15, 2016 | $0.57 | Quarterly |
Jun 18, 2015 | Aug 14, 2015 | Jul 15, 2015 | $0.51 | Quarterly |
Feb 19, 2015 | May 15, 2015 | Apr 15, 2015 | $0.51 | Quarterly |
Oct 20, 2014 | Feb 13, 2015 | Jan 15, 2015 | $0.49 | Quarterly |
Sep 19, 2014 | Nov 17, 2014 | Oct 15, 2014 | $0.42 | Quarterly |
Jun 19, 2014 | Aug 15, 2014 | Jul 15, 2014 | $0.42 | Quarterly |
Feb 20, 2014 | May 15, 2014 | Apr 15, 2014 | $0.42 | Quarterly |
Dec 12, 2013 | Feb 14, 2014 | Jan 15, 2014 | $0.4 | Quarterly |
Sep 19, 2013 | Nov 15, 2013 | Oct 15, 2013 | $0.4 | Quarterly |
Jun 20, 2013 | Aug 15, 2013 | Jul 15, 2013 | $0.4 | Quarterly |
Feb 15, 2013 | May 15, 2013 | Apr 15, 2013 | $0.4 | Quarterly |
Jan 4, 2013 | Feb 15, 2013 | Jan 15, 2013 | $0.4 | Quarterly |
Related Companies
View additional S&P 500 companies similar to ABBVIE INC. (ABBV)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.